MarketsandMarkets is providing a platform for pharmaceutical, biotechnology professionals and technology providers to come together at the BioGeNe 2019 Confex on the 7th & 8th Feb 2018 in San Diego-USA to discuss advancements and solutions to the most critical challenges in the Biomarker, Precision Medicine and Genome engineering areas.
With growing pressures of increasing success rates for FDA approved biomarkers as well as companion diagnostics tests has seen an outgrowth in drug discovery companies to invest in novel strategies for biomarker discovery. The industry of genome editing has witnessed some great breakthroughs during a year in the areas like genome writing, base editing and specific progression in the field of therapeutics through the Car-T cells and immunotherapy. As the era of personalized medicine is fast approaching, healthcare is becoming more personalized and tailored to the patient.
Clinical biomarker identification and qualification | Biomarkers and personalized medicine | Assay development and validation | NGS and novel technologies in biomarker discovery | Commercialization of biomarkers in therapeutic and CDx applications |Microbiomics and Metabolomics | NGS for Consumers, Patients, and Medical Systems | Role of AI in Precision Medicine | Conversational Intelligence Technologies for Patients and Consumers |Innovative Digital Health Technologies |Tools in Precision Medicine for Immuno-Oncology| Base editing through genome editing tools | Target efficiency | Homology directed repair mutations | Ethical issues for gene therapy | Precision gene editing | Diagnosis of therapy through CRISPR | Single cell base editing | Car-T cell therapy | Sickle cell disease treatment
Experts from academia and industry presenting their current work in Biomarkers
Latest updates on regulatory guidelines and approvals | Case studies from experts who have successfully created and developed a biomarker | Facilitated networking sessions to ensure quality interactions | One on one query handling by biomarker experts |Opportunity to develop long-lasting business relationships and networking opportunities with senior peers.
Who Should Attend
From Pharmaceutical and Bio-pharmaceutical companies:
Chief Scientific Officers/ Chief Executive Officer’s/Senior Scientists/ Principal Scientists/CMO/ CTO/ Director/ VP/ Head/ Manager/ Lead Architects/ Lead Engineers/ Group leaders/ Clinicians/ Practitioners (Physicians)/ Professors/ Project Leaders Heads in: